Development deals News
Most Popular Development deals Story
Wyeth stumbles badly trying to develop new drugs
The analysts have been picking over Wyeth's carcass over the past few days as they assess a string of woeful developments that have left the company stripped of three of its leading drug candidates. Read more...
Latest Headlines
- October 18, 2011
- October 13, 2011
- September 22, 2011
- September 15, 2011
- September 7, 2011
- May 31, 2011
- December 17, 2010
- October 26, 2010
- August 24, 2010
- January 21, 2010
- December 30, 2009
- December 18, 2009
- October 5, 2009
- September 28, 2009
- September 9, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
